Clinical Trial Update: A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on CD19 CAR-T cell therapy being studied in active systemic lupus erythematosus (Phase 1/Phase 2); currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• CD19 CAR-T cell therapy (CAR-T cell therapy targeting CD19)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: RECRUITING